Concerning BPC-157, a natural pentadecapeptide, that acts as a cytoprotectant and is believed to protect the gastro-intestinal tract (GIT).

Commentary on a review article

“This article discusses the lengthy review by Pedrag Sikiric and twenty one (21) co-authors in Inflammopharmacology (2024) 32:3119–3161.”

BPC-157 is described as a stable cytoprotectant in gastric juice with beneficial effects on GIT protection and cellular protection.

“The peptide was subsequently described as a cytoprotectant with the radical property of being stable in gastric juice and therefore accessible for both gastric and intestinal protection after oral administration.”

The 2024 review summarizes beneficial effects of BPC-157 in GIT protection and cellular protection across other organs.

“Table 1 (9 plus pages) summarising beneficial effects in the context of GIT protection; and Table 2 (14 plus pages) describing beneficial effects via cellular protection extended to other organ therapy.”

There are few reports of BPC-157's potential bio-regulant significance based on human studies.

“If BPC-157 is such an outstanding natural therapeutic agent (perhaps an endogenous hormone), why are there so few reports of its potential bio-regulant significance based on human studies?”